Geropharm 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GP40141 (romiplostim biosimilar) / Geropharm
NCT06497036: Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia

Active, not recruiting
3
160
RoW
GP404141, romiplostim, Nplate, romilostim
Geropharm, Pharm-Holding, I.M. Sechenov First Moscow State Medical University
Drug Effect, Safety Issues, Immunogenicity
03/28
03/28
NCT05652595: Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141

Recruiting
1
56
RoW
GP40141, romiplostim, Nplate, romilostim
Geropharm
Pharmacodynamics, Pharmacokinetics, Bioequivalence
06/24
09/24
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
GP40141 (romiplostim biosimilar) / Geropharm
NCT06497036: Study of Efficacy, Safety and Immunogenicity of GP40141 (GEROPHARM, Russia) in Patients With Immune Thrombocytopenia

Active, not recruiting
3
160
RoW
GP404141, romiplostim, Nplate, romilostim
Geropharm, Pharm-Holding, I.M. Sechenov First Moscow State Medical University
Drug Effect, Safety Issues, Immunogenicity
03/28
03/28
NCT05652595: Double-blind, Randomized Comparative Cross-sectional Study of Pharmacodynamics and Pharmacokinetics of Drugs GP40141

Recruiting
1
56
RoW
GP40141, romiplostim, Nplate, romilostim
Geropharm
Pharmacodynamics, Pharmacokinetics, Bioequivalence
06/24
09/24

Download Options